140 related articles for article (PubMed ID: 9721437)
1. Antisense oligodeoxynucleotides for organ transplantation.
Stepkowski SM
Clin Biochem; 1998 Jul; 31(5):375-9. PubMed ID: 9721437
[No Abstract] [Full Text] [Related]
2. Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease.
Yacyshyn BR; Chey WY; Goff J; Salzberg B; Baerg R; Buchman AL; Tami J; Yu R; Gibiansky E; Shanahan WR;
Gut; 2002 Jul; 51(1):30-6. PubMed ID: 12077088
[TBL] [Abstract][Full Text] [Related]
3. An oral formulation for intracellular adhesion molecules-1 antisense oligonucleotides.
Stepkowski SM; Chen W; Geary R; Wang ME; Condon T; Stecker K; Bennett CF
Transplant Proc; 2001; 33(7-8):3271. PubMed ID: 11750400
[No Abstract] [Full Text] [Related]
4. Phosphorothioate/methoxyethyl-modified ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury.
Stepkowski SM; Chen W; Bennett CF; Condon TP; Stecker K; Tian L; Kahan BD
Transplant Proc; 2001; 33(7-8):3705-6. PubMed ID: 11750578
[No Abstract] [Full Text] [Related]
5. Application of antisense oligodeoxynucleotides for organ transplantation.
Stepkowski SM
Transplant Proc; 1998 Aug; 30(5):2142-5. PubMed ID: 9723420
[No Abstract] [Full Text] [Related]
6. Protection against allograft rejection with intercellular adhesion molecule-1 antisense oligodeoxynucleotides.
Stepkowski SM; Wang ME; Condon TP; Cheng-Flournoy S; Stecker K; Graham M; Qu X; Tian L; Chen W; Kahan BD; Bennett CF
Transplantation; 1998 Sep; 66(6):699-707. PubMed ID: 9771832
[TBL] [Abstract][Full Text] [Related]
7. ISIS 2302. INXC ICAM1, Oligo-TCS.
Drugs R D; 1999 Jan; 1(1):85-6. PubMed ID: 10565996
[No Abstract] [Full Text] [Related]
8. ISIS 2302. Oligo-TCS.
Drugs R D; 1999 Mar; 1(3):265-7. PubMed ID: 10566042
[No Abstract] [Full Text] [Related]
9. Antisense ICAM-1 oligonucleotides block allograft rejection in rats.
Stepkowski SM; Wang ME; Amante A; Kalinin D; Qu X; Blasdel T; Condon T; Kahan BD; Bennett FC
Transplant Proc; 1997; 29(1-2):1285. PubMed ID: 9123308
[No Abstract] [Full Text] [Related]
10. Amelioration of hepatic ischemia/reperfusion injury with intercellular adhesion molecule-1 antisense oligodeoxynucleotides.
Ghobrial R; Amersi F; Stecker K; Kato H; Melinek J; Singer J; Mhoyan A; Busuttil RW; Kupiec-Weglinski JW; Stepkowski SM
Transplant Proc; 2001; 33(1-2):538. PubMed ID: 11266946
[No Abstract] [Full Text] [Related]
11. Phase I and phase II safety and efficacy trial of intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302) for the prevention of acute allograft rejection.
Kahan BD; Stepkowski S; Kilic M; Katz SM; Van Buren CT; Welsh MS; Tami JA; Shanahan WR
Transplantation; 2004 Sep; 78(6):858-63. PubMed ID: 15385805
[TBL] [Abstract][Full Text] [Related]
12. Alicaforsen. Isis Pharmaceuticals.
Gewirtz AT; Sitaraman S
Curr Opin Investig Drugs; 2001 Oct; 2(10):1401-6. PubMed ID: 11890355
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil--a new immunosuppressant for organ transplantation.
Med Lett Drugs Ther; 1995 Sep; 37(958):84-6. PubMed ID: 7674993
[No Abstract] [Full Text] [Related]
14. Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method.
Poston RS; Mann MJ; Hoyt EG; Ennen M; Dzau VJ; Robbins RC
Transplantation; 1999 Sep; 68(6):825-32. PubMed ID: 10515383
[TBL] [Abstract][Full Text] [Related]
15. Antisense Cdc2 kinase oligonucleotide inhibits adhesion molecule expression in cardiac allograft arteriopathy.
Suzuki J; Izawa A; Morishita R; Kaneda Y; Sawa Y; Okubo Y; Ogihara T; Sekiguchi M; Isobe M
Transplant Proc; 1999; 31(1-2):955-6. PubMed ID: 10083423
[No Abstract] [Full Text] [Related]
16. Prevention of renal ischemic reperfusion injury using FTY 720 and ICAM-1 antisense oligonucleotides.
Ortiz AM; Troncoso P; Kahan BD
Transplant Proc; 2003 Jun; 35(4):1571-4. PubMed ID: 12826223
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-masked, placebo-controlled study of alicaforsen, an antisense inhibitor of intercellular adhesion molecule 1, for the treatment of subjects with active Crohn's disease.
Yacyshyn B; Chey WY; Wedel MK; Yu RZ; Paul D; Chuang E
Clin Gastroenterol Hepatol; 2007 Feb; 5(2):215-20. PubMed ID: 17296530
[TBL] [Abstract][Full Text] [Related]
18. FTY720: mechanisms of action and its effect on organ transplantation (review).
Suzuki S
Transplant Proc; 1999 Nov; 31(7):2779-82. PubMed ID: 10578288
[No Abstract] [Full Text] [Related]
19. Perfusion of kidneys with unformulated "naked" intercellular adhesion molecule-1 antisense oligodeoxynucleotides prevents ischemic/reperfusion injury.
Chen W; Bennett CF; Wang ME; Dragun D; Tian L; Stecker K; Clark JH; Kahan BD; Stepkowski SM
Transplantation; 1999 Sep; 68(6):880-7. PubMed ID: 10515390
[TBL] [Abstract][Full Text] [Related]
20. The efficiency of humoral immune transfer depends on both the graft and the immunosuppressive treatment.
Dahmen U; Li J; Gu Y; Doebel L; Fan LM; Polywka S; Dirsch O; Broelsch CE
Transpl Int; 2003 Mar; 16(3):161-7. PubMed ID: 12664210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
